v3.23.2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2023	Sep. 30, 2022
Current Assets:
Cash and cash equivalents	$ 183,429	$ 85,637
Accounts receivable, net	968,016	586,270
Inventory	1,898,603	2,464,222
Prepaid expenses and other current assets	297,265	417,096
Total current assets	3,347,313	3,553,225
Property and equipment, net	24,602,289	21,019,724
Right of use asset	365,980	938,687
Construction escrow deposits	4,784,752	7,717,908
Deposits	44,114	86,604
Other assets	3,138,397	655,598
Assets held for sale	6,815,000	6,815,000
Intangible assets, net	10,852,835	11,741,487
Goodwill	58,064,816	58,233,386
Total Assets	112,015,496	110,761,619
Current Liabilities:
Accounts payable	6,852,306	6,422,196
Accrued payroll and payroll taxes	1,680,418	2,086,051
Accrued interest	8,387,582	3,070,415
Accrued expenses	2,048,325	3,328,222
Deferred revenue, current portion	174,997	219,992
Notes payable, current portion, net of discounts	29,522,607	15,924,033
Income tax payable	19,145	13,221
Operating lease liability, current portion	247,586	271,573
Convertible notes payable, net of discounts	4,380,000	3,750,000
Liabilities related to assets held for sale	5,500,000	5,500,000
Total current liabilities	58,812,966	40,585,703
Deferred revenue, net of current portion	413,359	335,859
Operating lease liability, net of current portion	144,867	682,752
Notes payables, net of current portion and discounts		7,216,710
Total liabilities	59,371,192	48,821,024
Stockholders' Equity:
Common stock, par value $.0001 per share, 2,000,000,000 shares authorized; 114,662,271 and 109,950,509 shares issued and 102,362,271 and 97,650,509 shares outstanding at June 30, 2023 and September 30, 2022	11,421	10,995
Additional paid-in capital	143,689,979	140,417,114
Accumulated deficit	(77,602,297)	(65,016,698)
Treasury stock	(13,450,000)	(13,450,000)
Total Item 9 Labs Corp. Stockholders' Equity	52,649,103	61,961,411
Non-controlling interest	(4,799)	(20,816)
Total Stockholders' Equity	52,644,304	61,940,595
Total Liabilities and Stockholders' Equity	$ 112,015,496	$ 110,761,619

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Item 9 Labs Corp. 10-Q